Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Antidepressant Hearings Offer Starting Point For Vioxx Investigation

Oct 11 2004

• By The Pink Sheet

Related Content

COX-2 Retrospective Study Prompts Review By FDA, Kaiser On Merck’s Vioxx

Aug 30 2004

Vioxx Withdrawal Fuels Criticism Of DTC; Liability Exposure May Be Test

Oct 11 2004

COX-2 Market Growth Could Be Stalled Until Release Of Long-Term Safety Data

Oct 04 2004

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window